Review



mr203485  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    OriGene mr203485
    Mr203485, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mr203485/Psmb5+(NM_011186)+Mouse+Tagged+ORF+Clone/pmc11896255__ACEL___24___e14492___s001-0-8-9
    Average 93 stars, based on 3 article reviews
    mr203485 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Plasmid Preparation:

    Article Title: Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer’s-like pathology in mouse and fly APP overexpression models
    Article Snippet: Cells were imaged with the Incucyte system (Sartorius), and images were analyzed with the manufacturer’s software for green fluorescent protein (GFP) fluorescence intensity normalized by cell confluence. .. A full-length mouse PSMB5 plasmid was used (MR203485, Origene). .. PSMB5 was excised to remove the Myc-DDK tag then cloned into the ShuttleNSE empty vector (50958, Addgene) adjacent to the NSE promoter.

    Article Title: Proteasome Augmentation Mitigates Age‐Related Cognitive Decline in Mice
    Article Snippet: .. NSE-PSMB5 A full-length mouse PSMB5 plasmid was used (MR203485, Origene). .. PSMB5 was excised to remove the Myc-DDK tag then cloned into the ShuttleNSE empty vector (50958, Addgene) adjacent to the NSE promoter.

    Article Title: Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer's-like pathology in mouse and fly APP overexpression models.
    Article Snippet: Cells were imaged with the Incucyte system (Sartorius), and images were analyzed with the manufacturer’s software for green fluorescent protein (GFP) fluorescence intensity normalized by cell confluence. .. A full-length mouse PSMB5 plasmid was used (MR203485, Origene). .. PSMB5 was excised to remove the Myc-DDK tag then cloned into the ShuttleNSE empty vector (50958, Addgene) adjacent to the NSE promoter.



    Similar Products

    93
    OriGene mr203485
    Mr203485, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mr203485/Psmb5+(NM_011186)+Mouse+Tagged+ORF+Clone/pmc11896255__ACEL___24___e14492___s001-0-8-9
    Average 93 stars, based on 1 article reviews
    mr203485 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    OriGene length mouse psmb5 plasmid
    Fig. 2. <t>PSMB5</t> overexpression increases proteasome function in mice and delays AD-like cognitive deficits and mortality. (A) NSE-PSMB5 transgenic mouse model. (B) Immunoblot of PSMB5 normalized to -actin, brains dissected from 3-month-old mice. NTG, N = 6; PSMB5, N = 7. (C) Native PAGE gel of brains dissected from 3-month-old mice; proteasome content and assembly assessed by incubation with the MV151 fluorescent proteasome probe. This is a broad proteasome inhibitor bind- ing to active centers and producing fluorescence. Values adjusted to total protein based on Coomassie staining. Purified 20S and 26S proteasome used to identify bands. NTG, N = 6; PSMB5, N = 7. (D) Relative proteasome peptidase (chymotrypsin-like) activity, brains dissected from 3-month-old mice (N = 5 to 6). Replicate samples were incubated with the proteasome inhibitor bortezomib. (E and F) NSE-PSMB5 reduces AD-like cell death (WST-1 assay) in MC65 AD cell culture model transfected with NSE- PSMB5, 4 days after tetracycline (TET) withdrawal, N = 24 samples per group. (G) NSE-PSMB5 mice crossed with hAPP(J20) AD model. (H to K) NSE-PSMB5 reduces AD-like learning and memory deficits in Morris water maze, Y maze, and novel object recognition assay. All animals were 7- to 8-month-old littermates; NTG, N = 15; PSMB5, N = 11; hAPP, N = 14; hAPP;PSMB5, N = 9. (L) NSE-PSMB5 protects against early mortality in hAPP(J20) mice; NTG, N = 38; PSMB5, N = 37; hAPP, N = 55; hAPP;PSMB5, N = 39. Animals are littermates. Significance was based on Student’s t test in (B) and (C). Significance was based on two-way ANOVA, followed by Tukey or Bonferroni post hoc test in (D), (F), (H), (J), and (K). Significance was based on log-rank test; *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 were used unless otherwise stated. N represents the number of animals or samples per group.
    Length Mouse Psmb5 Plasmid, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mr203485/Psmb5+(NM_011186)+Mouse+Tagged+ORF+Clone/pm35675410-367-1-8
    Average 93 stars, based on 1 article reviews
    length mouse psmb5 plasmid - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    OriGene psmb5 (nm_011186) mouse tagged orf clone
    Fig. 2. <t>PSMB5</t> overexpression increases proteasome function in mice and delays AD-like cognitive deficits and mortality. (A) NSE-PSMB5 transgenic mouse model. (B) Immunoblot of PSMB5 normalized to -actin, brains dissected from 3-month-old mice. NTG, N = 6; PSMB5, N = 7. (C) Native PAGE gel of brains dissected from 3-month-old mice; proteasome content and assembly assessed by incubation with the MV151 fluorescent proteasome probe. This is a broad proteasome inhibitor bind- ing to active centers and producing fluorescence. Values adjusted to total protein based on Coomassie staining. Purified 20S and 26S proteasome used to identify bands. NTG, N = 6; PSMB5, N = 7. (D) Relative proteasome peptidase (chymotrypsin-like) activity, brains dissected from 3-month-old mice (N = 5 to 6). Replicate samples were incubated with the proteasome inhibitor bortezomib. (E and F) NSE-PSMB5 reduces AD-like cell death (WST-1 assay) in MC65 AD cell culture model transfected with NSE- PSMB5, 4 days after tetracycline (TET) withdrawal, N = 24 samples per group. (G) NSE-PSMB5 mice crossed with hAPP(J20) AD model. (H to K) NSE-PSMB5 reduces AD-like learning and memory deficits in Morris water maze, Y maze, and novel object recognition assay. All animals were 7- to 8-month-old littermates; NTG, N = 15; PSMB5, N = 11; hAPP, N = 14; hAPP;PSMB5, N = 9. (L) NSE-PSMB5 protects against early mortality in hAPP(J20) mice; NTG, N = 38; PSMB5, N = 37; hAPP, N = 55; hAPP;PSMB5, N = 39. Animals are littermates. Significance was based on Student’s t test in (B) and (C). Significance was based on two-way ANOVA, followed by Tukey or Bonferroni post hoc test in (D), (F), (H), (J), and (K). Significance was based on log-rank test; *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 were used unless otherwise stated. N represents the number of animals or samples per group.
    Psmb5 (Nm 011186) Mouse Tagged Orf Clone, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mr203485/Psmb5+(NM_011186)+Mouse+Tagged+ORF+Clone/origene___mr203485
    Average 93 stars, based on 1 article reviews
    psmb5 (nm_011186) mouse tagged orf clone - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    Image Search Results


    Fig. 2. PSMB5 overexpression increases proteasome function in mice and delays AD-like cognitive deficits and mortality. (A) NSE-PSMB5 transgenic mouse model. (B) Immunoblot of PSMB5 normalized to -actin, brains dissected from 3-month-old mice. NTG, N = 6; PSMB5, N = 7. (C) Native PAGE gel of brains dissected from 3-month-old mice; proteasome content and assembly assessed by incubation with the MV151 fluorescent proteasome probe. This is a broad proteasome inhibitor bind- ing to active centers and producing fluorescence. Values adjusted to total protein based on Coomassie staining. Purified 20S and 26S proteasome used to identify bands. NTG, N = 6; PSMB5, N = 7. (D) Relative proteasome peptidase (chymotrypsin-like) activity, brains dissected from 3-month-old mice (N = 5 to 6). Replicate samples were incubated with the proteasome inhibitor bortezomib. (E and F) NSE-PSMB5 reduces AD-like cell death (WST-1 assay) in MC65 AD cell culture model transfected with NSE- PSMB5, 4 days after tetracycline (TET) withdrawal, N = 24 samples per group. (G) NSE-PSMB5 mice crossed with hAPP(J20) AD model. (H to K) NSE-PSMB5 reduces AD-like learning and memory deficits in Morris water maze, Y maze, and novel object recognition assay. All animals were 7- to 8-month-old littermates; NTG, N = 15; PSMB5, N = 11; hAPP, N = 14; hAPP;PSMB5, N = 9. (L) NSE-PSMB5 protects against early mortality in hAPP(J20) mice; NTG, N = 38; PSMB5, N = 37; hAPP, N = 55; hAPP;PSMB5, N = 39. Animals are littermates. Significance was based on Student’s t test in (B) and (C). Significance was based on two-way ANOVA, followed by Tukey or Bonferroni post hoc test in (D), (F), (H), (J), and (K). Significance was based on log-rank test; *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 were used unless otherwise stated. N represents the number of animals or samples per group.

    Journal: Science advances

    Article Title: Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer's-like pathology in mouse and fly APP overexpression models.

    doi: 10.1126/sciadv.abk2252

    Figure Lengend Snippet: Fig. 2. PSMB5 overexpression increases proteasome function in mice and delays AD-like cognitive deficits and mortality. (A) NSE-PSMB5 transgenic mouse model. (B) Immunoblot of PSMB5 normalized to -actin, brains dissected from 3-month-old mice. NTG, N = 6; PSMB5, N = 7. (C) Native PAGE gel of brains dissected from 3-month-old mice; proteasome content and assembly assessed by incubation with the MV151 fluorescent proteasome probe. This is a broad proteasome inhibitor bind- ing to active centers and producing fluorescence. Values adjusted to total protein based on Coomassie staining. Purified 20S and 26S proteasome used to identify bands. NTG, N = 6; PSMB5, N = 7. (D) Relative proteasome peptidase (chymotrypsin-like) activity, brains dissected from 3-month-old mice (N = 5 to 6). Replicate samples were incubated with the proteasome inhibitor bortezomib. (E and F) NSE-PSMB5 reduces AD-like cell death (WST-1 assay) in MC65 AD cell culture model transfected with NSE- PSMB5, 4 days after tetracycline (TET) withdrawal, N = 24 samples per group. (G) NSE-PSMB5 mice crossed with hAPP(J20) AD model. (H to K) NSE-PSMB5 reduces AD-like learning and memory deficits in Morris water maze, Y maze, and novel object recognition assay. All animals were 7- to 8-month-old littermates; NTG, N = 15; PSMB5, N = 11; hAPP, N = 14; hAPP;PSMB5, N = 9. (L) NSE-PSMB5 protects against early mortality in hAPP(J20) mice; NTG, N = 38; PSMB5, N = 37; hAPP, N = 55; hAPP;PSMB5, N = 39. Animals are littermates. Significance was based on Student’s t test in (B) and (C). Significance was based on two-way ANOVA, followed by Tukey or Bonferroni post hoc test in (D), (F), (H), (J), and (K). Significance was based on log-rank test; *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 were used unless otherwise stated. N represents the number of animals or samples per group.

    Article Snippet: A full-length mouse PSMB5 plasmid was used (MR203485, Origene).

    Techniques: Over Expression, Transgenic Assay, Western Blot, Clear Native PAGE, Incubation, Fluorescence, Staining, Purification, Activity Assay, WST-1 Assay, Cell Culture, Transfection

    Fig. 3. PSMB5 overexpression increases degradation of APP machinery. (A and B) Immunoblot of 70-day-old Elav-GS-GAL4>UAS-hAPP;UAS-hBACE1 and Elav-GS- GAL4>UAS-hAPP;UAS-hBACE1;UAS-Pros5 flies fed with 400 M RU-486. AD model, N = 12; AD + Pros5, N = 12. Values normalized by -actin. (C and D) Immunoblot of APP levels in SK-N-SH cells transfected with either NSE vector (control) or NSE-PSMB5, N = 3. (E) Images of SK-N-SH cells transfected with APPGFP and either the NSE vector or NSE-PSMB5, N = 6. (F) NSE-PSMB5 mice crossed with hAPP(J20) AD model. (G) Anti-APP immunoblots in 7- to 8-month-old hAPP(J20) ± NSE-PSMB5 mouse brains. APP, N = 9; APP;PSMB5, N = 9. Values normalized by -actin with quantification (left) and A42 ELISA (right); APP, N = 9; APP;PSMB5, N = 9. (H) X34 staining on brain coronal sections from hAPP(J20) ± NSE-PSMB5 mice, N = 3 per genotype. Number of plaques per hemibrain were quantified using ImageJ software. (I) Postmortem human hippo- campal tissue (patients with AD versus age-matched unaffected controls). (J) Postmortem human hippocampal tissue sample lysate, proteasome activity plotted against soluble A ELISA or anti-APP immunoblot (N = 35 in total, 11 controls and 24 patients with AD). (K to O) Postmortem human hippocampal tissue sample lysate, protea- some activity plotted against phosphorylated tau/total tau ratio (L), BACE1 (M), K48-polyubiquitinated (K48-UB) proteins (N), and total polyubiquitinated (poly-UB) pro- teins (O). N = 23. *P < 0.05 and ***P < 0.001. Significance is based on Student’s t test in (B), (E), (G), and (H). Significance was based on linear regression in (J) to (O). N represents the number of animals, samples, or patients per group.

    Journal: Science advances

    Article Title: Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer's-like pathology in mouse and fly APP overexpression models.

    doi: 10.1126/sciadv.abk2252

    Figure Lengend Snippet: Fig. 3. PSMB5 overexpression increases degradation of APP machinery. (A and B) Immunoblot of 70-day-old Elav-GS-GAL4>UAS-hAPP;UAS-hBACE1 and Elav-GS- GAL4>UAS-hAPP;UAS-hBACE1;UAS-Pros5 flies fed with 400 M RU-486. AD model, N = 12; AD + Pros5, N = 12. Values normalized by -actin. (C and D) Immunoblot of APP levels in SK-N-SH cells transfected with either NSE vector (control) or NSE-PSMB5, N = 3. (E) Images of SK-N-SH cells transfected with APPGFP and either the NSE vector or NSE-PSMB5, N = 6. (F) NSE-PSMB5 mice crossed with hAPP(J20) AD model. (G) Anti-APP immunoblots in 7- to 8-month-old hAPP(J20) ± NSE-PSMB5 mouse brains. APP, N = 9; APP;PSMB5, N = 9. Values normalized by -actin with quantification (left) and A42 ELISA (right); APP, N = 9; APP;PSMB5, N = 9. (H) X34 staining on brain coronal sections from hAPP(J20) ± NSE-PSMB5 mice, N = 3 per genotype. Number of plaques per hemibrain were quantified using ImageJ software. (I) Postmortem human hippo- campal tissue (patients with AD versus age-matched unaffected controls). (J) Postmortem human hippocampal tissue sample lysate, proteasome activity plotted against soluble A ELISA or anti-APP immunoblot (N = 35 in total, 11 controls and 24 patients with AD). (K to O) Postmortem human hippocampal tissue sample lysate, protea- some activity plotted against phosphorylated tau/total tau ratio (L), BACE1 (M), K48-polyubiquitinated (K48-UB) proteins (N), and total polyubiquitinated (poly-UB) pro- teins (O). N = 23. *P < 0.05 and ***P < 0.001. Significance is based on Student’s t test in (B), (E), (G), and (H). Significance was based on linear regression in (J) to (O). N represents the number of animals, samples, or patients per group.

    Article Snippet: A full-length mouse PSMB5 plasmid was used (MR203485, Origene).

    Techniques: Over Expression, Western Blot, Transfection, Plasmid Preparation, Control, Enzyme-linked Immunosorbent Assay, Staining, Software, Activity Assay